The article I researched investigated the
relationship between obesity and an excess amount of insulin and their link to
increased prostate cancer. It can be accessed here. It’s also mentioned,
interestingly enough, that long-standing diabetes may actually be protective
against prostate cancer development. It’s said that diabetes can be associated
with insulin depletion and decreased insulin like growth factor 1 signaling.
Androgens (hormones) and other metabolic factors may also promote prostate
cancer using many mechanisms.
There has recently been an increased interest in the
role of metabolic factors in the pathogenesis of prostate cancer. Since
prostate cancer is a hormone-dependent growth, it would be expected that you
can control prostate cancer growth by depriving men of androgens. This therapy continues
to evolve, however it has actually been linked to an increased risk of
diabetes.
The authors discuss the links between geographic location
and the prevalence of prostate cancer. An example of this is that Asian men
living in the United States have much higher prostate cancer rates than those
living in Asian countries. However, with further study, there is a relatively
weak association between BMI and prostate cancer. The risk increase was
significant only for advanced disease. Therefore, it’s hypothesized that
obesity may actually reduce the risk of non-aggressive prostate cancer.
Studying 19 population-based studies between 1971
and 2005 show that men with diabetes had a 16 percent reduction in their risk
of prostate cancer. However, this only occurred from at least five years after
the diabetes diagnosis. Studies have concluded that there is a much larger
decreased risk of prostate cancer in men with diabetes after a longer period of
time from when they’re diagnosed. Some explanations for the protective effect
of diabetes include the progressive development of beta cell exhaustion with
insulin depletion, simple genetic factors, or the association of diabetes with
lower testosterone and insulin growth factor 1 levels.
One can see the possible mechanisms involved with
the effects of metabolic risk factors on prostate cancer in the figure. This shows that diabetes and prostate cancer sort of stem from the same
shared environmental factors and genetic background. Additionally, a prolonged
duration of diabetes and reduced insulin may lead to a decreased risk of prostate
cancer. It’s been said that the overall mortality rates among men who developed
prostate cancer have been linked with diabetes and a higher risk of cancer case
fatality.
In conclusion, there’s an important relationship between
obesity and aggressive prostate cancer, and a worse outcome. Things like
increased insulin, obesity effects in steroid levels, and disturbances in
metabolism may all be important with regards to prostate cancer. This field is
attracting more and more research because of the increased prominence of
prostate cancer, now worldwide, and the epidemic of obesity/diabetes.
--Blake